Ahmed Y. Elnagar, Ph.D. - Publications

Affiliations: 
2010 University Of Louisiana at Monroe 
Area:
Pharmacy

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Orabi KY, Abaza MS, El Sayed KA, Elnagar AY, Al-Attiyah R, Guleri RP. Selective growth inhibition of human malignant melanoma cells by syringic acid-derived proteasome inhibitors. Cancer Cell International. 13: 82. PMID 23958424 DOI: 10.1186/1475-2867-13-82  0.446
2013 Ji Y, Majumder S, Millard M, Borra R, Bi T, Elnagar AY, Neamati N, Shekhtman A, Camarero JA. In vivo activation of the p53 tumor suppressor pathway by an engineered cyclotide. Journal of the American Chemical Society. 135: 11623-33. PMID 23848581 DOI: 10.1021/Ja405108P  0.364
2012 Sayed KAE, Elnagar AY, Khanfar M. Abstract 4778: Computer-assisted molecular design use for the discovery and optimization of rationally-designed anticancer natural products. Discovery of olive oil-derived oleocanthal as a c-Met inhibitor and optimization of Veratrum alkaloids as Hedgehog signaling inhibitors Cancer Research. 72: 4778-4778. DOI: 10.1158/1538-7445.Am2012-4778  0.709
2011 Hassan HM, Elnagar AY, Khanfar MA, Sallam AA, Mohammed R, Shaala LA, Youssef DT, Hifnawy MS, El Sayed KA. Design of semisynthetic analogues and 3D-QSAR study of eunicellin-based diterpenoids as prostate cancer migration and invasion inhibitors. European Journal of Medicinal Chemistry. 46: 1122-30. PMID 21334794 DOI: 10.1016/J.Ejmech.2011.01.028  0.662
2011 Elnagar AY, Sylvester PW, El Sayed KA. (-)-Oleocanthal as a c-Met inhibitor for the control of metastatic breast and prostate cancers. Planta Medica. 77: 1013-9. PMID 21328179 DOI: 10.1055/S-0030-1270724  0.577
2010 Behery FA, Elnagar AY, Akl MR, Wali VB, Abuasal B, Kaddoumi A, Sylvester PW, El Sayed KA. Redox-silent tocotrienol esters as breast cancer proliferation and migration inhibitors. Bioorganic & Medicinal Chemistry. 18: 8066-75. PMID 20943398 DOI: 10.1016/J.Bmc.2010.09.009  0.656
2010 Hassan HM, Khanfar MA, Elnagar AY, Mohammed R, Shaala LA, Youssef DT, Hifnawy MS, El Sayed KA. Pachycladins A-E, prostate cancer invasion and migration inhibitory Eunicellin-based diterpenoids from the red sea soft coral Cladiella pachyclados. Journal of Natural Products. 73: 848-53. PMID 20420415 DOI: 10.1021/Np900787P  0.677
2010 Abdel Bar FM, Khanfar MA, Elnagar AY, Badria FA, Zaghloul AM, Ahmad KF, Sylvester PW, El Sayed KA. Design and pharmacophore modeling of biaryl methyl eugenol analogs as breast cancer invasion inhibitors. Bioorganic & Medicinal Chemistry. 18: 496-507. PMID 20034800 DOI: 10.1016/J.Bmc.2009.12.019  0.7
2010 Elnagar AY, Wali VB, Sylvester PW, El Sayed KA. Design and preliminary structure-activity relationship of redox-silent semisynthetic tocotrienol analogues as inhibitors for breast cancer proliferation and invasion. Bioorganic & Medicinal Chemistry. 18: 755-68. PMID 20022507 DOI: 10.1016/J.Bmc.2009.11.054  0.504
2009 Bar FM, Khanfar MA, Elnagar AY, Liu H, Zaghloul AM, Badria FA, Sylvester PW, Ahmad KF, Raisch KP, El Sayed KA. Rational design and semisynthesis of betulinic acid analogues as potent topoisomerase inhibitors. Journal of Natural Products. 72: 1643-50. PMID 19691293 DOI: 10.1021/Np900312U  0.668
Show low-probability matches.